Status:

COMPLETED

A Feasibility Study to Improve Colorectal Cancer Screening Among Racially Diverse Zip Codes in a Persistent Poverty County Using Navigation and Machine Learning Predictive Algorithms

Lead Sponsor:

Abramson Cancer Center at Penn Medicine

Conditions:

Colorectal Cancer

Eligibility:

All Genders

Brief Summary

The overarching goals of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) sc...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients residing in 18 zip codes in Western and Southwestern Philadelphia who have primary care providers in 4 Penn Medicine Internal Medicine practices and 3 Penn Medicine Family Medicine Practices
  • Patients who have had a colonoscopy order placed in the past 6 months and have not scheduled, cancelled, or no-showed to their colonoscopy

Exclusion

    Key Trial Info

    Start Date :

    March 29 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2024

    Estimated Enrollment :

    201 Patients enrolled

    Trial Details

    Trial ID

    NCT05383976

    Start Date

    March 29 2022

    End Date

    November 1 2024

    Last Update

    November 22 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Pennsylvania

    Philadelphia, Pennsylvania, United States, 19104